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Objectives: To investigate he presence of Chlamydia pneumoniae DNA in the wall of infrarenaI abdominal ortic 
aneurysms, and in the walt of non-aneurysmal infrarenal abdominal ortas. 
Design: Case-control study. 
Materials and methods: The study group consisted of40 patients operated transperitoneally for an infrarenal abdominal 
aortic aneurysm (IAAA) (eight females, 32 males; mean age 69 years, median age 68 years). Specimens from the aneurysm 
wall were taken peroperatively under sterile conditions. The control group consisted of40 deceased persons without aortic 
aneurysms (14 femates, 26 males; mean age 71 years, median age 70 years). Specimens from the non-aneurysmaI infrarenal 
aortas (NIAA) were collected within 48 h after death. The specimens from both groups were frozen at - 70 °C immediately 
after collection. A nested polymerase chain reaction (PCR) method, using two sets of primers designed todetect afragment 
of the major outer membrane protein gene of C. pneumoniae, was used. 
Results: The detection ofC. pneumoniae-specific DNA was significantly higher in the study group (14/40 = 35%) than 
in the control group (2/40=5%); (p=O.OOI). No clinical factor predicting the presence of C. pneumoniae in the 
aneurysm wall, could be found. 
Conclusion: Chlamydia pneumoniae was detected ata significantly higher frequency in the wall of IAAAs than in 
the wall of NIAAs. Although this finding does not prove that C. pneumoniae causes IAAAs, further studies on the 
possible role of C. pneumoniae in the pathogenesis of aneurysms should be performed. 
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Introduction 
The pathogenesis of abdominal aortic aneurysms in- 
volves a complex interaction of a variety of factors, 
acting over many years, resulting in weakening and 
dilatation of the aortic wall. Inflammation, de- 
gradation, and remodelling are characteristics of the 
aneurysmatic wall of the aorta. ~ However, the factor(s) 
initiating this process is still unknown. 
Chlamydia pneumoniae, an obligate intracellular bac- 
teria, is one of three known Chlamydia species with 
the ability to infect humans, and has been shown to 
be a common cause of pneumonia nd bronchitis in 
both adults 2and children. 3 Several seroepidemiological 
studies have shown an association between C. pneu- 
moniae and atherosclerotic coronary artery 4-6 and 
cerebrovascular 7 diseases. Chlamydia pneumoniae an- 
tigen has been demonstrated in atherosclerotic lesions 
of the coronary arteries, the aorta and the carotid 
* Please address all correspondence to: E. Petersen, Department of 
Surgery, Umek University Hospital, S-901 85 Ume&, Sweden. 
arteries by immunocytochemistry, polymerase chain 
reaction (PCR) and electron microscopy, s-l~ but there 
is a remarkable variation in the detection rate of C. 
pneumoniae in atherosclerotic ssue between different 
research groups. 12-14 
In vitro studies have shown that C. pneumoniae isol- 
ates can grow in human endothelial cells, smooth 
muscle cells and macrophages. 15-17 Chlamydia pneu- 
moniae has been cultured from atherosclerotic 
plaques .4'~8 and early and intermediate lesions of 
atherosclerosis in the aorta were observed in animals 
shortly after infection with C. pneumoniae. ~9"2° 
Chlamydia pneumoniae is clearly linked to the ath- 
erosclerotic plaques in occlusive vascular disease and 
may be important in the degenerative ascular disease 
of aneurysms. The constant finding of an inflammatory 
process of varying degree in the aneurysm wall might 
suggest some infectious agent in the pathogenesis. It 
has been proposed that aneurysmal dilatation partially 
represents an immune-mediated disease, ~but the sig- 
nals initially attracting the leucocytes into the vessel 
wall are unknown. Chlamydia pneumoniae might be 
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able to deliver such a signal. Previous studies have 
demonstrated C. pneumoniae in aortic aneurysms. 21-23 
However, none of these studies included acomparable- 
control group. Because the majority of elderly subjects 
have or have had an infection with C. pneumoniae, 24 
the finding of C. pneumoniae in the non-aneurysmal 
infrarenal aorta could be expected to be as frequent 
as in aneurysmal infrarenal aorta. The aim of this 
study was to investigate whether C. pneumoniae was 
as prevalent in the wall of aneurysmal s compared to 
non-aneurysmal infrarenal abdominal orta of patients 
with comparable age. The aim was also to investigate 
whether there was a difference in the clinical features 
between the groups of C. pneumoniae DNA-positive 
and -negative aneurysm patients. 
Materials and Methods 
Materials 
Study group. From January 1995 to April 1996, 40 
patients were operated on for infrarenal abdominal 
aortic aneurysm (IAAA). The indications for operation 
were an aneurysm ore than 5 cm in cross-sectional 
diameter, rupture or suspected rupture. There were 
eight (20%) females and 32 (80%) males. Fifteen of 
them were operated as emergency cases, the others 
electively. The mean age was 69 years, median 68 
years. A piece of aortic tissue was taken peroperatively 
from the anterior wall of the IAAAs from all 40 patients 
and the tissue was immediately frozen at -70 °C 
under sterile conditions. From 37 of the patients a 
serum sample was collected preoperatively. Anamnestic 
information of familial occurrence of aneurysms, mok- 
ing habits, pulmonary disease, symptomatic coronary 
heart disease, hypertension a d aneurysm-related symp- 
toms were obtained. Aneurysm diameter, macroscopic 
signs of aneurysm inflammation and C-reactive protein 
(CRP) were measured. Informed consent was obtained 
from all patients. 
Control group. Tissue from non-aneurysmal infrarenal 
abdominal aorta (NIAA) was collected under clean, 
non-sterile, conditions of 40 consecutive autopsies per- 
formed at the Department of Pathology and the De- 
partment of Forensic Medicine, Ume~, within 48 h 
after death. After collection the tissues were handled 
sterile, and immediately frozen at -70 °C. The speci- 
mens were collected from 14 females (35%) and 26 
males (65%) (mean age was 71 years, median 72 years) 
according to the Law of Transplantation (SFS 1975: 
190). 
Method of analysis 
In both groups the aortic wall was cleaned from blood 
and fatty tissue and the IAAAs also from intraluminal 
thrombi. For each aneurysmatic and non-aneurysmatic 
infrarenal aorta, one biopsy of approximately 25 mg 
was analysed. The frozen tissues were thawed on ice 
and cut into small pieces under sterile conditions and 
DNA was purified by using the QIAamp Tissue kit 
(QIAGEN Inc., Chatsworth, CA, U.S.A.). A part of the 
major outer membrane protein gene (MOMP) of C. 
pneumoniae was chosen as the target for amplification 
in a nested touchdown PCR, with primers as described 
earlier by Tong and Sillis. 25 All specimens were ana- 
lysed twice and repeated incases of a discrepant result. 
Only repeatedly positive specimens were accepted 
as true positive. Positive and negative controls were 
included in each analysis and all 80 biopsies were 
analysed by PCR for the presence of 6-globin DNA to 
ensure that DNA was present in the samples. 26
A serum sample from 37 of the IAAA patients was 
analysed for C. pneumoniae-specific IgG, IgA and IgM 
antibodies by the microimmunofluorescence test (Lab- 
systems, Helsinki, Finland). Titres >_ 1:32 for IgG and 
__ 1:16 for IgA and IgM were regarded as cut-off for 
presence of C. pneumoniae antibodies. Post-mortem 
serum samples from the control patients were not 
obtainable. 
SPSS version 6.1.3 was used to test the significance 
of differences.'The Fisher exact (two-tailed) test was 
used. A p-value <0.05 was regarded as significant. 
Results 
Presence of DNA 
Chlamydia pneumoniae DNA was repetitively detected 
in 14 (35%; 10 men and four women) of the 40 IAAA 
samples. In the control group, C. pneumoniae DNA was 
detected in two (5%; one man and one woman) of the 
40 cases (p = 0.001). In all samples, {~-globin DNA was 
detected and positive and negative controls for PCR 
all reacted appropriately. The PCR result was equivocal 
in seven samples of the study group and in six control 
samples, and was scored negative. 
No correlation could be shown between a positive 
or negative PCR result and gender, age, smoking 
habits, pulmonary disease, coronary heart disease, 
hypertension, aneurysm related symptoms, familial 
occurrence of aneurysms, aneurysm diameter, macro- 
scopic signs of inflammation or CRP. 
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Presence of antibodies 
The majority of the IAAA patients were C. pneumoniae 
IgG (32/37) and IgA (26/37) seropositive. All sera 
were C. pneumoniae IgM-negative. From the 14 patients 
with a positive PCR result, we were able to analyse 
13 serum samples. Eleven out of the 13 samples were 
IgG-seropositive and 5 IgA-seropositive. 
Discussion 
We found a significantly higher frequency of C. pneu- 
moniae DNA in the aneurysm group than in the control 
group. Chlamydia pneumoniae has also been found in 
abdominal aortic aneurysms by Ong et al. 21 using PCR 
and immunofluorescence staining, by Blasi et aI. 22 
using PCR and by Juvonen et al. 23 using immuno- 
histochemistry, electronmicroscopy and PCR. 
The significantly lower frequency of C. pneumoniae 
DNA in the control group could be due to post-mortem 
autolysis and destruction of the bacteria. However, C. 
pneumoniae DNA has been found in vascular tissue 
from deceased patients in the same frequency as in 
fresh tissue. 1°'27 We applied a nested PCR for detection 
of C. pneumoniae which has been shown to be superior 
to one-step PCR.  28"29 Analysis of more than one biopsy 
from the same aneurysm may increase the number of 
cases positive for C. pneumoniae DNA. 22 Our figures 
could therefore be an underestimation, as we only 
analysed one biopsy from every aneurysm. Chlamydia 
pneumoniae has been detected in atherosclerotic aortic 
tissue, but not in normal tissue. ~°'22 Detection of C. 
pneumoniae in two controls is to be expected, as the 
control samples were collected from elderly people, 
frequently having atherosclerosis. As infection with C. 
pneumoniae is very common 24 it could be argued that 
C. pneumoniae will occur in every diseased body tissue 
and therefore be the explanation for the high detection 
rate of C. pneumoniae DNA in the aneurysms. However, 
Muhlestein et al. 12 showed recently that C. pneumoniae 
was not a frequent finding in arteries diseased by 
processes other than atherosclerosis. 
The high frequency of C. pneumoniae IgG-sero- 
positive patients was expected, as the seroprevalence 
(IgG titres >1:16) among people more than 40 years 
of age has been shown to be 40-70%. 24 Eleven out of the 
13 available serum samples from the 14 C. pneumoniae 
DNA-positive aneurysm patients were IgG-sero- 
positive. This shows a good accordance between PCR 
and serology. High accordance between PCR and sero- 
logy is not always present. 8 That might be due to a 
protective function of high titres of circulating anti- 
body in PCR-negative patients. In contrast, PCR-posi- 
tive patients with a chronic infection could be antibody 
non-responders, or the bacteria in the vessel wall may 
be unable to stimulate circulating antibody. Chlamydia 
pneumoniae IgA was detected in 70% (26/37) of the 
IAAA serum samples and this could indicate an on- 
going C. pneumoniae infection. 5 
No correlation could be seen between a positive or 
negative PCR result and different anamnestic and 
objective variables. This is not surprising, because of 
the relatively small number of patients. 
The fact that C. pneumoniae DNA was detected sig- 
nificantly more often in IAAAs than in NIAAs does 
not prove that C. pneumoniae causes aneurysms. De- 
tection of viable bacteria from the aneurysm wall by 
culture might indicate participation in the inflam- 
matory process in abdominal aortic aneurysms. How- 
ever, even the presence of viable bacteria could be 
an epiphenomenon without pathological significance. 
Many studies point out a possible role of C. pneumoniae 
in the development of atherosclerosis, 8-14'18-2° but a 
study finding no evidence has also been published. I3
Regarding C. pneumoniae in aneurysms, only a few 
studies have been published, and all of them have 
found an increased prevalence of C. pneumoniae in 
aneurysms compared to controls. Generalisation is 
premature because of the risk of publication bias; 
however, finding a known human pathogen in the 
wall of abdominal aortic aneurysms creates many 
hypotheses about a possible role of C. pneumoniae in
aneurysm development. 
Familial clustering of abdominal aortic aneurysms 3° 
suggests a genetic omponent in the pathogenesis, but 
no precise genetic basis of aneurysm formation has 
yet been shown. Different host defence mechanisms, 
possibly genetically determined, against a C. pneu- 
moniae infection, involving differentiated CD4 T-cells 
to Thl or Th2 phenotype, might explain the de- 
velopment of different vascular lesions such as an- 
eurysmal and occlusive disease. 31 Data from human 
chlamydial infections are scarce, but in vitro studies 
have shown that cytokines are critical in the host 
defence against intracellular bacteria. Interferon- 
gamma (IFN-7) probably plays a predominant role 
because it can suppress intracellular eplication of 
Chlamydiae completely or cause persistent infection 
and contribute to the disease process with inflam- 
mation and f ib ros i s .  32 A number of cytokines are sig- 
nificantly increased in aneurysmal aortic tissue, 
including INF-T. 33'34 Therefore, studies investigating 
the host defence reaction against intracellular bacteria 
such as C. pneumoniae could be of interest. The an- 
eurysmal dilatation has been proposed to represent 
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an immune-mediated disease ~and a persistent C. pneu- 
moniae infection might be i nvo lved .  6'32'35 
Abdominal aortic aneurysms are typically char- 
acterised by chronic inflammation of varying intensity 
throughout the aortic wall, and the inflammatory cells 
play an important role in the degradation of the extra- 
cellular matrix. 36 Degradation of elastin and increased 
collagen synthesis are recognised as key elements in 
aneurysm formation. 37 Matrix metalloproteases 38'39 and 
leucocyte lastase 4°have been shown to participate 
in the degradation of the vessel wall. It has been 
shown that genital Chlamydia trachomatis infection sig- 
nificantly enhances granulocyte-elastase levels in 
urine, 41 and the presence of a unique proteinase on 
the surface of Chlamydia psittaci elementary bodies was 
reported by Stokes et al. 42 Chlamydia pneumoniae might 
harbour a similar protease which could initiate an 
enzymatic degradation of the extracellular matrix and 
lead to aneurysm development. Once the degradation 
of elastin has started, elastin-derived peptides might 
stimulate smooth muscle cells to secrete lastase, 43and 
an autonomous process to begin. In vitro studies on 
aortic tissue infected with C. pneumoniae might give 
an answer as to whether C. pneumoniae has the ability 
to start the degenerative process. 
The possibility of a chronic C. pneumoniae infection 
participating in the pathogenesis of aneurysms awakes 
speculations on the therapeutic use of antibiotics. A 
chronic C. pneumoniae infection continuing after an- 
eurysm surgery might be of importance to the fre- 
quently observed ilatation of the supra-aneurysmal 
aorta after surgery. This could be of significance con- 
sidering late prosthetic leakage or loosening after en- 
dovascular aortic aneurysm surgery. The influence 
of a possible chronic C. pneumoniae infection on the 
vascular graft is unknown, but some degree of weak- 
ening might be possible. The aneurysm obviously 
represents he end-stage of a long pathological process 
in the aortic wall, and might be considered as a "scar". 
Consequently, the results of analysis on aneurysms 
must be interpreted with caution. Focusing on the 
early stages of aneurysm development might elucidate 
whether C. pneumoniae has a role in aneurysm for- 
mation or not. 
In conclusion, C. pneumoniae DNA was detected in 
a significantly higher frequency in IAAAs than in 
NIAAs. Studies investigating the possible role of C. 
pneumoniae in the pathogenesis of aneurysms are re- 
quired. 
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